ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

This study has been completed.

Study NCT00090363 Information provided by AstraZeneca

First Received: August 25, 2004 Last Updated: September 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2011
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: May 23, 2011